Priorities for Clinical Research in Pediatric Extracorporeal Membrane Oxygenation Anticoagulation From the Pediatric

Jennifer A Muszynski1, Melania M Bembea2, Alison Gehred3

  • 1Department of Pediatrics, Division of Critical Care Medicine, Nationwide Children's Hospital and The Ohio State University, Columbus, OH.

Insights

Pediatric experts identified research priorities for anticoagulation and hemostasis in neonates and children on extracorporeal membrane oxygenation (ECMO). Further research is needed in five key domains to improve care for these critically ill patients.

Area of Science:

  • Pediatric critical care medicine
  • Hematology
  • Cardiopulmonary support

Background:

  • Extracorporeal membrane oxygenation (ECMO) is a life-support measure for critically ill neonates and children.
  • Anticoagulation and hemostasis management during ECMO is complex and requires careful consideration.

Purpose of the Study:

  • To identify and prioritize critical research questions for anticoagulation and hemostasis in pediatric ECMO.
  • To inform future research and improve clinical management strategies.

Main Methods:

  • Systematic literature review of PubMed, EMBASE, and Cochrane Library (CENTRAL) from 1988 to 2021.
  • Consensus conferences involving international, interprofessional experts in pediatric ECMO.
  • Application of the Child Health and Nutrition Research Initiative methodology for research prioritization.

Main Results:

  • Twenty research topics were prioritized by the Pediatric ECMO Anticoagulation CollaborativE (PEACE) panel.
  • Prioritized topics fall into five domains: definitions and outcomes, therapeutics, anticoagulant monitoring, protocolized management, and ECMO circuit impact on hemostasis.
  • Established a framework for future research in pediatric ECMO anticoagulation and hemostasis.

Conclusions:

  • The PEACE panel has outlined crucial research priorities for pediatric ECMO.
  • Addressing these research gaps is essential for advancing the care and improving outcomes for neonates and children on ECMO.
  • Further investigation is needed to optimize anticoagulation and hemostasis management in this vulnerable population.
Abstract